HIGHLIGHTS
- who: Leopoldo Sitia and collaborators from the IRCCS Istituti Clinici Scientifici Salvatore Maugeri, Pavia, Italy have published the research work: HER-2-Targeted Nanoparticles for Breast Cancer Diagnosisand Treatment, in the Journal: Cancers 2022, 2424 of /2022/
- what: The aim of this review is to provide a first critical update on the different types of HER-2-targeted nanoparticles that have been proposed in the literature in the last decade for therapeutic purposes. The authors focus on the different targeting strategies that have been explored their relative outcomes and current limitations that still need to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.